GlassScriptPhysician profile
Alberto Anthony Goizueta
NPI 1760864045
$10,136.15
in general payments reported to CMS, 2019-2025
17 companies · $3,592 in 2025
The $3,592 reported for 2025 was more than what 85% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $24.13 · 2021: $218 · 2022: $156 · 2023: $2,285 · 2024: $3,526 · 2025: $3,592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,120 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,048 · Travel and Lodging: $1,978 · Education: $1,250 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,119.74 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,047.50 |
| Travel and Lodging | $1,977.79 |
| Education | $1,250.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,091.97 | 2023-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Cook Incorporated | $2,047.50 | 2025 | |
| Pulmonx Corporation | $545.34 | 2023-2025 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Medtronic, INC. | $501.57 | 2022-2024 | Illumisite |
| Erbe USA INC | $300.00 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $217.71 | 2021 | |
| Cook Medical LLC | $212.45 | 2025 | Blue Rhino |
| Penumbra, INC. | $174.46 | 2025 | Indigo System |
| Innovation Technologies INC | $173.86 | 2025 | Irrisept |
| Galvanize Therapeutics, INC | $172.29 | 2024 | Aliya System |
| Coaptech, INC. | $163.57 | 2025 | Puma System |
| La Jolla Pharmaceutical Company | $152.19 | 2019 | |
| United Therapeutics Corporation | $124.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $112.20 | 2025 | |
| Olympus America INC. | $64.93 | 2023-2025 | Spiration Valve System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $56.99 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $24.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Goizueta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.